FdaApplication

NDA 205098

Back to search

Identifiers

Properties

PropertyValue
applicant_nameBOSTON SCIENTIFIC CORP
application_typeNDA
approval_date2013-11-25

Products (2)

ProductActive ingredientStrengthDosage form
VARITHENAPOLIDOCANOL77.5MG/7.75ML (10MG/ML)SOLUTION;INTRAVENOUS
VARITHENAPOLIDOCANOL180MG/18ML (10MG/ML)SOLUTION;INTRAVENOUS

2 products